Gene · 2202
Papers1,739
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,739
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel pathogenesis concept of biliary atresia approached by combined molecular strategies. | PLoS One | 2022 | 36350824 | PubTator, text mining | PubMed |
| Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation. | Clin Proteomics | 2022 | 36348270 | PubTator, text mining | PubMed |
| Gene co-expression network analysis revealed novel biomarkers for ovarian cancer. | Front Genet | 2022 | 36338962 | PubTator, text mining | PubMed |
| Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy. | J Transl Med | 2022 | 36335375 | PubTator, text mining | PubMed |
| M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. | BMC Cancer | 2022 | 36333719 | PubTator, text mining | PubMed |
| Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A Comprehensive Pan-Cancer Analysis. | J Oncol | 2022 | 36304987 | PubTator, text mining | PubMed |
| The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling. | Front Oncol | 2022 | 36303838 | PubTator, text mining | PubMed |
| Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer's Disease. | Metabolites | 2022 | 36295851 | PubTator, text mining | PubMed |
| Dissecting Polygenic Etiology of Ischemic Stroke in the Era of Precision Medicine. | J Clin Med | 2022 | 36294301 | PubTator, text mining | PubMed |
| The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment. | Cancers (Basel) | 2022 | 36291929 | PubTator, text mining | PubMed |
| Progeria and Aging-Omics Based Comparative Analysis. | Biomedicines | 2022 | 36289702 | PubTator, text mining | PubMed |
| [Overview of Biliary Atresia]. | J Korean Soc Radiol | 2022 | 36276222 | PubTator, text mining | PubMed |
| Naïve pluripotent-like characteristics of non-tumorigenic Muse cells isolated from human amniotic membrane. | Sci Rep | 2022 | 36241699 | PubTator, text mining | PubMed |
| Oxidative-Damaged Mitochondria Activate GABARAPL1-Induced NLRP3 Inflammasomes in an Autophagic-Exosome Manner after Acute Myocardial Ischemia. | Oxid Med Cell Longev | 2022 | 36238641 | PubTator, text mining | PubMed |
| Cancer-associated Fibroblasts Communicate with Breast Tumor Cells Through Extracellular Vesicles in Tumor Development. | Technol Cancer Res Treat | 2022 | 36222020 | PubTator, text mining | PubMed |
| Muscle fibro-adipogenic progenitors from a single-cell perspective: Focus on their "virtual" secretome. | Front Cell Dev Biol | 2022 | 36200044 | PubTator, text mining | PubMed |
| Identification of Monocyte-Associated Genes Related to the Instability of Atherosclerosis Plaque. | Oxid Med Cell Longev | 2022 | 36187340 | PubTator, text mining | PubMed |
| A genome-wide association study to investigate genetic loci associated with primary glaucoma in American Cocker Spaniels. | Am J Vet Res | 2022 | 36170212 | PubTator, text mining | PubMed |
| Omphalocele and biliary atresia: chance or causality. A case report. | Einstein (Sao Paulo) | 2022 | 36169552 | PubTator, text mining | PubMed |
Exploring the mutational landscape of genes associated with inherited retinal disease using large genomic datasets: identifying loss of function intolerance and outlying propensities for missense changes. | BMJ Open Ophthalmol | 2022 | 36161854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2202/papers?page=19